Pharmaceutical intermediates
Fexuprazan HCl Intermediates
2 pharmaceutical intermediates for Fexuprazan HCl. Indication: Erosive esophagitis; Gastroesophageal reflux disease.
About Fexuprazan HCl
- Originator
- Daewoong Pharmaceutical Co., Ltd
- Indication
- Erosive esophagitis; Gastroesophageal reflux disease
Available intermediates
2 intermediates currently listed for Fexuprazan HCl. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate | 1902955-29-6 | / | / |
| 3-Fluorobenzenesulfonyl chloride | 701-27-9 | / | / |
Building toward Fexuprazan HCl?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →